Provided by Tiger Trade Technology Pte. Ltd.

SINOMAB BIO-B

1.100
+0.0252.33%
Volume:666.00K
Turnover:709.51K
Market Cap:1.53B
PE:-11.02
High:1.120
Open:1.075
Low:1.030
Close:1.075
52wk High:2.740
52wk Low:0.990
Shares:1.39B
HK Float Shares:1.39B
Volume Ratio:0.90
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.100
ROE:-29.96%
ROA:-9.63%
PB:2.57
PE(LYR):-11.02
PS:228.34

Loading ...

Sinomab BioScience Reports Stable Share Capital in June; 11.09 Million Options Lapse

Bulletin Express
·
Jul 07

Sinomab Bioscience - Announces Major Deal for Disposal of Suzhou Property and Facility for Rmb280 Mln

THOMSON REUTERS
·
Jul 06

Sinomab Bioscience to Sell Suzhou Property, Facility for RMB 280 Million

Reuters
·
Jul 06

SinoMab BioScience Adds Chief Operating Officer Fang Liang to Board as Executive Director

Bulletin Express
·
Jul 03

SINOMAB BIO-B Appoints Liang Fang as Executive Director

Stock News
·
Jul 03

Sinomab Bioscience Files Board, Board Committee and Management Disclosure List

Reuters
·
Jul 03

Sinomab Bioscience Appoints COO Fang Liang as Executive Director

Reuters
·
Jul 03

Sinomab Bioscience - Appoints Fang Liang as Executive Director Effective 3 July 2026

THOMSON REUTERS
·
Jul 03

SINOMAB BIO-B Appoints Xue Lei as Non-Executive Director

Stock News
·
Jun 12

SinoMab BioScience: AGM Resolutions Secure 100% Support; Lei Xue Named Non-Executive Director

Bulletin Express
·
Jun 12

Hong Kong Stock Movement | SINOMAB BIO-B Surges Over 25% in Late Trading on Robust Pipeline and High BD Potential

Stock News
·
Jun 11

Sinomab Bio-B Maintains 1.39 Billion Issued Shares and Public Float Compliance in May 2026 Return

Bulletin Express
·
Jun 04

SinoMab Presents Preclinical Study Data of Vitiligo, Alopecia Drug at Dermatology Conference

MT Newswires Live
·
May 14

Revised Title

Stock News
·
May 14

Sinomab Bioscience posts unchanged share capital and maintains public float in April 2026 monthly return

Bulletin Express
·
May 06

SinoMab BioScience releases 2025 ESG report

Reuters
·
Apr 27

SinoMab BioScience unveils 2026 AGM agenda: board changes, 10% share buy-back mandate and 20% issuance limit

Bulletin Express
·
Apr 27

SinoMab BioScience announces annual general meeting

Reuters
·
Apr 27

SinoMab BioScience publishes 2025 annual report

Reuters
·
Apr 27

君实生物(SINOMAB BIO-B)2025年显著减亏,股本增长强化资金实力

Bulletin Express
·
Apr 27